Fecal Incontinence Clinical Trial
Official title:
LIBERATE - PRO: An Extended Use Registry to Further Develop Understanding of the Long Term Use of the Eclipse™ System for Fecal Incontinence in Women Via Patient Reported Outcomes
A prospective, open label post market registry to collect Patient Reported Outcomes in an online data capture registry, maintained by Pelvalon, of women with fecal incontinence exiting the LIBERATE study (NCT02428595) continuing to use the Eclipse System for bowel control.
All LIBERATE (NCT02428595) study participants who complete the 12 month visit will be invited
to participate in the LIBERATE-PRO post market registry in an effort to obtain additional
long term quality of life and economic data. Subjects will be sent an email with a link to
the survey(s) or mailed printed surveys depending on chosen survey delivery option to be
completed at 3, 6, 9, and 12 months.Baseline will be defined as the baseline value in the
LIBERATE study, prior to the insertion of the Eclipse System.
The St. Mark's (Vaizey) Incontinence Severity Score will be used to assess the severity of
accidental bowel leakage at 3, 6, 9, and 12 months in comparison to how it was prior to
joining the LIBERATE study. The score is based on 7 questions and is a measure of severity of
fecal incontinence (FI) symptoms, which has been shown to correlate with improvement in
frequency of FI episodes and subjects' perceptions of relief. The composite score calculated
from these questions reflects the severity of FI and ranges from 0 (complete continence) to
24 (complete incontinence). The change from baseline score will be calculated at each time
point. The average change from baseline score, computed as the mean change from baseline
across all completed assessments, will be calculated.
The Patient Global Impression of Improvement (PGI-I) is a validated global index used to rate
the response of a condition to a therapy on a scale from 1 (Very much better) to 7 (Very much
worse). The PGI-I will be used to assess improvement of accidental bowel leakage at 3, 6, 9,
and 12 months in comparison to how it was prior to joining the LIBERATE study. The average
PGI-I score, computed as the mean score across all completed assessments, will be calculated.
The FIQOL (Fecal Incontinence Quality of Life Questionnaire will be completed at 12 months.
The Fecal Incontinence Quality of Life (FIQOL) scale is a 41-item, validated questionnaire
completed by the subject. FIQOL has 4 subscales: lifestyle, coping/behavior,
depression/self-perception and embarrassment. Each subscale score ranges from 1 to 5, with 1
indicating a lower functional status of quality of life. FIQOL score will be used to assess
the changes in quality of life in each of the subscales in comparison to the same scores
prior to joining the LIBERATE study.The change from baseline in each of the 4 subscale scores
(lifestyle, coping/behavior, depression/self-perception, embarrassment) will be calculated.
The Eclipse Experience feedback (questions related to perceptions of device comfort,
satisfaction with usage and features, and impact on daily activities) will be collected at 3,
6, 9, and 12 months.
All outcomes will be summarized descriptively at each time point.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03825575 -
Sacral Neuromodulation as Treatment for Fecal Incontinence
|
N/A | |
Completed |
NCT00605826 -
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
|
N/A | |
Withdrawn |
NCT02208258 -
Efficacy, Safety, and Performance Study of a Novel Device Designed to Manage Fecal Incontinence in Hospitalized Bedridden Patients With Liquid to Semi-formed Stool.
|
N/A | |
Completed |
NCT01939821 -
A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes
|
N/A | |
Completed |
NCT01957969 -
French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Recruiting |
NCT00530933 -
Tibial Nerve Stimulation for Faecal Incontinence
|
N/A | |
Withdrawn |
NCT00522691 -
Efficacy of Sacral Nerve Stimulation Before Definitive Implantation
|
N/A | |
Completed |
NCT00565136 -
Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms
|
Phase 1/Phase 2 | |
Completed |
NCT00677508 -
Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling
|
||
Completed |
NCT05032534 -
Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence
|
N/A | |
Completed |
NCT05058326 -
Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
|
||
Completed |
NCT03746834 -
NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation
|
Phase 4 | |
Completed |
NCT00124904 -
Biofeedback for Fecal Incontinence
|
N/A | |
Completed |
NCT04097288 -
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
|
Phase 1 | |
Completed |
NCT05621629 -
Management of FI After Surgery of ARM
|
||
Withdrawn |
NCT04138602 -
BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence
|
N/A | |
Completed |
NCT03252951 -
Physical Therapy for Anal Incontinence
|
N/A | |
Completed |
NCT04478799 -
Transcutaneous Posterior Nerve Stimulation inTreatment of Fecal Incontience
|
N/A | |
Withdrawn |
NCT00307476 -
Comparison of Rectal Trumpet and Standard Care
|
N/A |